Visits: 3753, Avg visit time (secs): 406,56 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 1806 | 48,12% | |
| /lilly/programme/efsd-lilly-rfa08.html | 676 | 18,01% |
| /programmes.html | 493 | 13,14% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa08.html | 178 | 4,74% |
| /msd/albert-renold/efsd-msd-arenold.html | 46 | 1,23% |
| /gsk/efsd-gsk-rfa08.html | 43 | 1,15% |
| /novo-t2/efsd-novo-t2-rfa08.html | 37 | 0,99% |
| /home.html | 29 | 0,77% |
| /novartis/efsd-novartis-rfa09.html | 24 | 0,64% |
| /lilly/programme/efsd-lilly-cds-fellowship08.htm | 22 | 0,59% |
| /regulations.html | 19 | 0,51% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1641 | 43,73% |
| /lilly/programme/efsd-lilly-rfa08.html | 689 | 18,36% |
| /programmes.html | 322 | 8,58% |
| /msd/albert-renold/efsd-msd-arenold.html | 256 | 6,82% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa08.html | 123 | 3,28% |
| /home.html | 86 | 2,29% |
| /gsk/efsd-gsk-rfa08.html | 63 | 1,68% |
| /novo-t2/efsd-novo-t2-rfa08.html | 37 | 0,99% |
| /lifescan/efsd-lifescan-rfa09.html | 31 | 0,83% |
| /lilly/fellowships/efsd-lilly-fship09.html | 31 | 0,83% |
| /pfizer/efsd-pfizer-rfa09.html | 25 | 0,67% |